DK1001789T3 - Produkt omfattende mindst en dobbeltstrenget RNA, der er kombineret med mindst et 6-benzyluracilderivat, til en simultan, separeret eller tidsforskudt terapeutisk anvendelse - Google Patents

Produkt omfattende mindst en dobbeltstrenget RNA, der er kombineret med mindst et 6-benzyluracilderivat, til en simultan, separeret eller tidsforskudt terapeutisk anvendelse

Info

Publication number
DK1001789T3
DK1001789T3 DK98941526T DK98941526T DK1001789T3 DK 1001789 T3 DK1001789 T3 DK 1001789T3 DK 98941526 T DK98941526 T DK 98941526T DK 98941526 T DK98941526 T DK 98941526T DK 1001789 T3 DK1001789 T3 DK 1001789T3
Authority
DK
Denmark
Prior art keywords
product
benzyluracil
derivative
stranded rna
simultaneous
Prior art date
Application number
DK98941526T
Other languages
English (en)
Inventor
Eric Ruhlmann
Original Assignee
Sod Conseils Rech Applic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sod Conseils Rech Applic filed Critical Sod Conseils Rech Applic
Application granted granted Critical
Publication of DK1001789T3 publication Critical patent/DK1001789T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
DK98941526T 1997-08-04 1998-08-03 Produkt omfattende mindst en dobbeltstrenget RNA, der er kombineret med mindst et 6-benzyluracilderivat, til en simultan, separeret eller tidsforskudt terapeutisk anvendelse DK1001789T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9709974A FR2766711B1 (fr) 1997-08-04 1997-08-04 Produit comprenant au moins un arn double brin en association avec au moins un devire du 6-benzyluracile pour une utilisation therapeutique simultanee, separee ou etalee dans le temps
PCT/FR1998/001726 WO1999007384A1 (fr) 1997-08-04 1998-08-03 Produit comprenant au moins un arn double brin en association avec au moins un derive du 6-benzyluracile

Publications (1)

Publication Number Publication Date
DK1001789T3 true DK1001789T3 (da) 2003-03-10

Family

ID=9510012

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98941526T DK1001789T3 (da) 1997-08-04 1998-08-03 Produkt omfattende mindst en dobbeltstrenget RNA, der er kombineret med mindst et 6-benzyluracilderivat, til en simultan, separeret eller tidsforskudt terapeutisk anvendelse

Country Status (10)

Country Link
EP (1) EP1001789B1 (da)
AT (1) ATE227132T1 (da)
AU (1) AU8987198A (da)
DE (1) DE69809246T2 (da)
DK (1) DK1001789T3 (da)
ES (1) ES2187056T3 (da)
FR (1) FR2766711B1 (da)
NO (1) NO20000554L (da)
PT (1) PT1001789E (da)
WO (1) WO1999007384A1 (da)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4950652A (en) * 1987-03-23 1990-08-21 Hem Research, Inc. dsRNAs for combination therapy in the treatment of viral diseases

Also Published As

Publication number Publication date
PT1001789E (pt) 2003-03-31
EP1001789B1 (fr) 2002-11-06
ES2187056T3 (es) 2003-05-16
FR2766711A1 (fr) 1999-02-05
AU8987198A (en) 1999-03-01
EP1001789A1 (fr) 2000-05-24
ATE227132T1 (de) 2002-11-15
DE69809246T2 (de) 2003-08-28
NO20000554D0 (no) 2000-02-03
NO20000554L (no) 2000-02-03
WO1999007384A1 (fr) 1999-02-18
FR2766711B1 (fr) 2001-02-02
DE69809246D1 (de) 2002-12-12

Similar Documents

Publication Publication Date Title
ES2171039T3 (es) Producto que comprende al menos un rna bicatenario en asociacion con al menos un interferon para el tratamiento de la hepatitis viral.
TR200002355T2 (tr) 2-(Pürin-9-il)tetrahidrofüran-3,4-diol türevleri
IL130931A0 (en) Small molecules useful in the treatment of inflammatory disease
SV1995000007A (es) Derivados del acido micofenolico 5-substituidos.
CY1106602T1 (el) Παραγωγα αδαμαντανιου για τη θεραπεια φλεγμονωδων, ανοσολογικων και καρδιαγγειακων ασθενειων
DK1036058T3 (da) Adamantanderivater
DK1036059T3 (da) Adamantanderivater
WO1998016507A3 (de) Neue heterocyclylmethyl-substituierte pyrazolederivate und ihre verwendung in des behandlung von herz-kreislauf-erkrankungen
FI963070A0 (fi) Klooripyrimidiinivälituotteita
FI965040A7 (fi) Uusia substituoituja purinyylijohdannaisia joilla on immunomoduloiva aktiivisuus
DK1490490T3 (da) Antisense IAP--nukleobase-oligomerer og anvendelser deraf
IL127918A0 (en) Novel amino sugar and related sugar derivatives of indolylopyrrolocarbazoles their use as antitumor agents and pharmaceutical formulations
TR199901949T2 (xx) Lemfositik t�m�rler i�in �areler.
NO975977D0 (no) Substituerte purinderivater, fremgangsmåter for fremstilling og anvendelse derav
DK0915845T3 (da) Acryloylsubstituerede distamycinderivater, fremgangsmåde til fremstilling deraf og anvendelse som antitumormidler og antivirale midler
ZA973883B (en) Distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents.
AU2921999A (en) Indole-2,3-dione-3-oxime derivatives for therapeutic use
DK1001789T3 (da) Produkt omfattende mindst en dobbeltstrenget RNA, der er kombineret med mindst et 6-benzyluracilderivat, til en simultan, separeret eller tidsforskudt terapeutisk anvendelse
AR029451A1 (es) Una composicion para su uso en la terapia del cancer de mamas en seres humanos y un producto para su uso en dicha terapia
WO2003090674A3 (en) Compounds, compositions and methods for treating or preventing viral infections and associated diseases
MXPA01012500A (es) Productos para terapia de gen.
DZ2159A1 (fr) Produits pharmaceutiques.
DK1011329T3 (da) 7-Methylthiooxomethyl- og 7-methylthiodioxomethyl-paclitaxeler
DK0980379T3 (da) Chimære oligonucleotider og deres anvendelse
CO4790095A1 (es) Derivados de tienoxacinona inhibodores de la proteasa del herpes